Search Results - "Deepak, MB"
-
1
-
2
-
3
Plasmablastic Myeloma- A Diagnostic Dilemma
Published in Journal of clinical and diagnostic research (01-05-2023)“…Plasmablastic neoplasms comprise various haematolymphoid tumours with plasmablastic morphology which includes Plasmablastic Myeloma (PBM) and Plasmablastic…”
Get full text
Journal Article -
4
Plasmablastic MyelomaA Diagnostic Dilemma
Published in Journal of clinical and diagnostic research (2023)“…Plasmablastic neoplasms comprise various haematolymphoid tumours with plasmablastic morphology which includes Plasmablastic Myeloma (PBM) and Plasmablastic…”
Get full text
Journal Article -
5
Postinjection Delirium/Sedation Syndrome After 31st Long-Acting Olanzapine Depot Injection
Published in Clinical neuropharmacology (01-03-2019)“…Long-acting depot preparations of antipsychotics are the mainstay of treatment for patients with schizophrenia who show nonadherence to their medications…”
Get full text
Journal Article -
6
Cardiovascular Risk Assessment of Liver Transplantation Candidates
Published in Journal of the American College of Cardiology (13-12-2011)“…(1) on cardiovascular risk assessment of candidates for liver transplantation (LT) and would like to congratulate the investigators on a comprehensive and…”
Get full text
Journal Article -
7
Clozapine Induced Hypertension and its Association with Autonomic Dysfunction
Published in Psychopharmacology bulletin (03-11-2021)“…Clozapine is a second generation antipsychotic agent which is drug of choice for treatment resistant schizophrenia. Tachycardia and postural hypotension are…”
Get full text
Journal Article -
8
In Reply to Trekker Behavior as One Indicator of AMS Knowledge
Published in Wilderness & environmental medicine (01-03-2010)Get full text
Journal Article -
9
Trekkers' Awareness of Acute Mountain Sickness and Acetazolamide
Published in Wilderness & environmental medicine (2008)Get full text
Journal Article -
10
COVID-19 vaccine acceptability in patients with opioid dependence – a cross-sectional, community-based study
Published in Journal of substance use (02-09-2024)Get full text
Journal Article -
11
Reinfusion of Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies Is Feasible with Sustained Responses
Published in Blood (02-11-2023)“…Background: Varnimcabtagene autoleucel, a CD19 directed CAR-T cell therapy with a 4-1BB co-stimulatory domain and a non-FMC63 based murine scFv (A3B1 binder),…”
Get full text
Journal Article -
12
Primary Analysis of Varnimcabtagene Autoleucel (IMN-003A) in Phase 2 Study (IMAGINE), a First-in-India Industry CD19-Directed CAR-T Cell Therapy for Patients with Relapsed Refractory B Cell Malignancies
Published in Blood (02-11-2023)“…Background: Varnimcabtagene autoleucel (IMN-003A) is an autologous second-generation CAR-T cell product with a 4-1BB co-stimulatory domain and a non-FMC63…”
Get full text
Journal Article -
13
Varnimcabtagene Autoleucel (IMN-003A): Pharmacokinetic Profile with Predominant Naïve and Central Memory Phenotype Demonstrates Sustained In Vivo Persistence and Durable Responses in a First-in-India Industry Phase-2 Study (IMAGINE)
Published in Blood (02-11-2023)“…Background: Varnimcabtagene autoleucel (IMN-003A) is an autologous CD19 directed CAR-T cell product with a 4-1BB co-stimulatory domain and a non-FMC63 murine…”
Get full text
Journal Article -
14
Factors Associated with Refractoriness or Relapse after Varnimcabtagene Autoleucel (IMN-003A) in Patients with Relapsed Refractory B Cell Malignancies: Phase 2 First-in-India Industry (IMAGINE) Study
Published in Blood (02-11-2023)“…Background: Varnimcabtagene autoleucel (IMN-003A) is an anti-CD19 CAR-T cell immunotherapy for patients with relapsed refractory B cell malignancies (RR BCM)…”
Get full text
Journal Article -
15
Response, Peak and Persistence of Varnimcabtagene Autoleucel (IMN-003A), First-in-India Industry CD19-Directed CAR-T Cell Therapy, with Fractionated Infusions for Patients with Relapsed and/or Refractory B Cell Malignancies: Early Results (IMAGINE Study)
Published in Blood (15-11-2022)Get full text
Journal Article -
16
Early Results from a Phase-2 Study of Varnimcabtagene Autoleucel (IMN-003A), a First-in-India Industry CD19-Directed CAR-T Cell Therapy with Fractionated Infusions for Patients with Relapsed and/or Refractory B Cell Malignancies (IMAGINE Study)
Published in Blood (15-11-2022)Get full text
Journal Article -
17
Reply to Prevention of Acute Mountain Sickness in Nepali Porters: A Controlled Trial
Published in Wilderness & environmental medicine (01-03-2007)Get full text
Journal Article